2026. Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma with GEMCAP and mFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes. Voprosy onkologii. 72, 1 (Mar. 2026), OF-2421. DOI:https://doi.org/10.37469/0507-3758-2026-72-1-OF-2421.